GREATER CHINA Sector Healthcare Bi-Weekly: Expecting strong 1H25 results. Maintain OVERWEIGHT. Results Contemporary Amperex Technology (300750 CH/BUY/Rmb277.09 /Target: Rmb390.00) 2Q25: Earnings in line, with margins hitting record-high levels. Maintain A-share at BUY. Downgrade H-share to HOLD. New Oriental Education & Technology Group (EDU US/BUY/US$44.37/Target: US$55.00) ...
TFG reported a record-high earnings of Bt2,037m, surging 1,072% yoy and 138% qoq, beating our and consensus estimates by 12% due to gross profit margin. Looking forward, we expect TFG to report another record-high earnings in 2Q25 on the back of better ASPs and lower raw material costs qoq. We foresee potential upside to our and consensus forecasts for 2025. Maintain BUY. Target price: Bt6.70.
KEY HIGHLIGHTS Results Bangchak Corporation (BCP TB/BUY/Bt38.00/Target: Bt45.00) 1Q25: Soft results, but better than expected; likely to see a strong rebound in 2Q25. COM7 (COM7 TB/BUY/Bt21.20/Target: Bt29.50) 1Q25: Better-than-expected earnings. CP ALL (CPALL TB/BUY/Bt51.50/Target: Bt79.00) 1Q25: Stronger-than-expected earnings. GFPT Plc. (GFPT TB/BUY/Bt9.80/Target: Bt13.40) ...
We expect a record-high core profit of Bt111.8b for 1Q25, up 2033% yoy and 59% qoq on the back of a strong improvement in gross profit margin. TFG’s 2Q25 earnings are also expected to reach a new high given the better qoq ASP momentum. We have raised our 2025-26 forecasts to reflect the better-than-expected livestock prices. Maintain BUY. Target price: Bt6.70.
KEY HIGHLIGHTS Sector Banking 1Q25: Results beat; banks prioritise less on loan growth. Downgrade to MARKET WEIGHT. Results Bumrungrad Hospital (BH TB/BUY/Bt169.00/Target: Bt232.00) 1Q25: Weak results in line with expectations. Update Thai Foods Group (TFG TB/BUY/Bt5.05/Target: Bt6.70) Expect record-high earnings in 1Q25 and 2Q25. Thanachart Capital (TCAP TB/HOLD/Bt47.00/Target: Bt48....
GREATER CHINA Results Aier Eye Hospital Group (300015 CH/BUY/Rmb12.72/Target: Rmb17.80) 2024: Satisfactory results; expects strong recovery in 2025. Upgrade to BUY. Ningbo Tuopu Group Co (601689 CH/BUY/Rmb50.96/Target: Rmb83.00) 4Q24: Earnings up 38.5% yoy, in line. Maintain BUY with target price unchanged at Rmb83.00. TAL Educational Group (TAL US/BUY/US$9.36/Target: US$14.00) 4QFY25: Earnings miss amid ramped-up investments in AI-powered learning. INDONESIA Sector Telecommun...
GREATER CHINA Strategy China And Hong Kong Property & Hong Kong Landlord Tariffs curtail US rate cuts, thereby hindering the recovery of Hong Kong property and tourism; Maintain OVERWEIGHT on China property. INDONESIA Strategy Alpha Picks: Outperform In Mar 25 Remove BBNI, BBRI, ASII, JSMR and KLBF; add BBCA, ICBP, ERAA and BUKA. MALAYSIA Update Pekat Group (PEKAT MK/BUY/RM1.08/Target: RM1.45) Good earnings visibility over 2025...
GREATER CHINA Results China Mengniu Dairy (2319 HK/BUY/HK$19.50/Target: HK$23.60) 2024: Results in line with profit warning; operating margin beat; targeting low single digit revenue growth for 2025. China Merchants Bank (3968 HK/HOLD/HK$45.90/Target: HK$49.00) 2024: Improving fundamentals but valuation is no longer attractive; downgrade to HOLD. China Overseas Property Holdings (2669 HK/BUY/HK$5.47/Target: HK$6.80) ...
We reiterate our positive view on TFG following its solid business outlook for both the short and long term. We foresee strong earnings improvement for 1Q25 following the rally in domestic and Vietnamese swine prices. We estimate a 13.4% yoy earnings growth for 2025. Looking forward, we expect its retail shop and Vietnam businesses to be its new S-curve of growth over the long term. Maintain BUY. Target price: Bt6.00.
GREATER CHINA Strategy Small-Mid Cap Monthly Reiterate BUY on JBM Healthcare. Sector Automobile Weekly: PV sales decline wow due to seasonal factors. Maintain MARKET WEIGHT on the sector. Top BUYs: Geely, CATL, Fuyao and Desay SV. Results Ping An Healthcare and Technology Company (1833 HK/BUY/HK$7.72/Target:HK$11.00) 2024: Satisfactory results; expect ...
TFG reported a core profit of Bt1,139m for 4Q24, up from a core loss of Bt984m in 4Q23, and flat qoq, in line with our and consensus forecasts. Looking forward, we expect to see a continuous earnings improvement in 2025 on the back of strong Vietnamese swine prices, an improvement in domestic livestock prices, and an expansion of its retail business. Maintain BUY. Target price: Bt6.00.
KEY HIGHLIGHTS Results BTS Group Holdings (BTS TB/HOLD/Bt6.20/Target: Bt4.79) 3QFY25: Core earnings to remain in the red. Thanachart Capital (TCAP TB/HOLD/Bt50.75/Target: Bt52.00) 4Q24: Earnings below expectations, despite THANI reporting a huge qoq reduction in credit cost. The One Enterprise (ONEE TB/HOLD/Bt3.16/Target: Bt3.10) 4Q24: Earnings below expe...
GREATER CHINA Update Shenzhen Mindray Bio-Medical Electronics (300760 CH/BUY/Rmb257.82/Target: Rmb330.00) Embraces business opportunities provided by digital and intelligent solutions. INDONESIA Update Dayamitra Telekomunikasi (MTEL IJ/BUY/Rp640/Target: Rp820) Expanding fibre optic network length by 20% following the acquisition. Maintain BUY. MALAYSIA Results MISC (MISC MK/BUY/RM7.15/Target: RM8.60) 2024: Results outperform, but marke...
GREATER CHINA Strategy Alpha Picks: January Conviction Calls Add CATL, JD Logistics, Miniso and Plover Bay to our BUY list, and Weimob to our SELL list. INDONESIA Strategy Alpha Picks: Our Selections Outperform In 2024 Our picks are ISAT, KLBF, BMRI, BBRI, EXCL, CTRA, JSMR, BBNI, CMRY and ASII. MALAYSIA Update VS Industry (VSI MK/BUY/RM1.16/Target: RM1.50) Despite a 17% recovery in its share price since its low in m...
We reaffirm our positive view on TFG for both the short and long terms. We expect 4Q24 earnings to come in slightly higher qoq. We still foresee huge potential for the fresh food shop business over the long term with its advantage over both local shops and big modern trade stores. TFG has also expanded its farm business to Vietnam to capture potential growth in the future. Maintain BUY. Target price: Bt6.00.
We are still positive on TFG’s outlook in 2025 given the strong Vietnam business outlook and the expansion of its retail business. We also expect lower pressure from raw material costs to support the profitability of the company. We revised up 2024-25 earnings by 31% and 19% respectively to reflect the resilient operations outlook. We expect 2025 earnings to grow 5.3% yoy. Maintain BUY. Target price: Bt6.00.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.